Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)

Am Heart J. 2010 Sep;160(3):e21; author reply e23. doi: 10.1016/j.ahj.2010.06.016.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin / administration & dosage*
  • Cilostazol
  • Clopidogrel
  • Drug Therapy, Combination
  • Drug-Eluting Stents*
  • Humans
  • Myocardial Infarction / prevention & control*
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Registries
  • Stents
  • Tetrazoles / administration & dosage*
  • Thrombosis / prevention & control*
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives*
  • Time Factors

Substances

  • Platelet Aggregation Inhibitors
  • Tetrazoles
  • Clopidogrel
  • Cilostazol
  • Ticlopidine
  • Aspirin